Delphia Therapeutics
Manufacturing · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1 Kendall Sq Bldg 200 Ste 1, Cambridge, ...Website
www.delphiatx.comRevenue
<$5 MillionIndustry
About Delphia Therapeutics
Delphia Therapeutics is pioneering a next-generation precision medicine approach known as activation lethality, which targets cancer's vulnerability to oncogene overactivation. The company aims to develop new cancer medicines that are effective on their own while addressing the emergence of resistance to traditional targeted therapies. With a distinguished team experienced in progressing new cancer medicines from discovery to commercialization, Delphia is committed to reimagining the function of cancer treatments. The company is actively seeking talented individuals to join its fast-growing team.Explore more
Delphia Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Delphia Therapeutics Tech Stack
A closer look at the technologies used by Delphia Therapeutics
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Delphia Therapeutics
Sign Up For FreeTo access detailed company insights
Delphia Therapeutics is pioneering a next-generation precision medicine approach known as activation lethality, which targets cancer's vulnerability to oncogene overactivation. The company aims to develop new cancer medicines that are effective on their own while addressing the emergence of resistance to traditional targeted therapies. With a disti... Read More
